MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 69 filers reported holding MEI PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,033,058 | +17.3% | 13,250,582 | +24.8% | 0.25% | -41.7% |
| Q4 2022 | $2,586,535 | +45.1% | 10,617,959 | +130.3% | 0.43% | +103.3% |
| Q3 2022 | $1,782,000 | -36.1% | 4,610,423 | 0.0% | 0.21% | -18.9% |
| Q2 2022 | $2,789,000 | +34.2% | 4,610,423 | +33.6% | 0.26% | +55.1% |
| Q1 2022 | $2,079,000 | -72.2% | 3,449,809 | +23.4% | 0.17% | -77.2% |
| Q4 2021 | $7,467,000 | +5310.9% | 2,796,510 | +3190.0% | 0.73% | +1182.5% |
| Q1 2017 | $138,000 | -93.0% | 85,000 | -93.8% | 0.06% | -90.7% |
| Q4 2016 | $1,968,000 | -21.5% | 1,366,859 | -25.8% | 0.62% | +28.9% |
| Q2 2016 | $2,506,000 | -69.3% | 1,842,493 | -25.0% | 0.48% | -60.3% |
| Q1 2016 | $8,169,000 | +162.6% | 2,455,793 | +26.3% | 1.20% | +19.5% |
| Q4 2015 | $3,111,000 | +50.4% | 1,944,479 | +47.7% | 1.01% | +67.7% |
| Q3 2015 | $2,068,000 | +326.4% | 1,316,925 | +364.1% | 0.60% | +164.8% |
| Q2 2015 | $485,000 | -9.2% | 283,749 | +127.0% | 0.23% | -64.0% |
| Q4 2014 | $534,000 | – | 125,000 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 3,018,059 | $4,467,000 | 4.40% |
| CAXTON CORP | 885,560 | $1,426,000 | 1.56% |
| Vivo Capital, LLC | 9,784,422 | $15,753,000 | 1.43% |
| Sio Capital Management, LLC | 2,485,098 | $4,001,000 | 1.34% |
| BVF INC/IL | 5,046,272 | $8,124,000 | 0.76% |
| NEA Management Company, LLC | 8,533,072 | $13,738,000 | 0.72% |
| Boxer Capital, LLC | 2,913,091 | $4,690,000 | 0.32% |
| Perceptive Advisors | 3,030,440 | $4,879,000 | 0.13% |
| WASATCH ADVISORS LP | 5,070,718 | $8,164,000 | 0.08% |
| KNOTT DAVID M | 38,590 | $62,000 | 0.04% |